These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 2901773)

  • 1. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sporadic and hereditary forms of medullary thyroid carcinoma.
    Rosenberg-Bourgin M; Gardet P; de Sahb R; Schlumberger M; Caillou B; Guilloud-Bataille M; Travagli JP; Feingold N; Parmentier C
    Henry Ford Hosp Med J; 1989; 37(3-4):141-3. PubMed ID: 2576948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of medullary carcinoma of the thyroid.
    Block MA
    Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
    Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
    N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family screening in medullary thyroid carcinoma presenting without a family history.
    Ponder BA; Finer N; Coffey R; Harmer CL; Maisey M; Ormerod MG; Pembrey ME; Ponder MA; Rosswick P; Shalet S
    Q J Med; 1988 Apr; 67(252):299-308. PubMed ID: 2905066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N; Ahuja S; Diel F
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
    Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
    Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MEN 2A syndrome: report of a family].
    Krassowski J; Gabryelewicz MB; Jeske W; Zgliczyński S
    Pol Merkur Lekarski; 2000 Jul; 8(49):481-2. PubMed ID: 11070721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma.
    González-Villalpando C; Madero A; Peña J; Ramírez R; Szymansky J; Ruiz JE; Zárate A
    Arch Invest Med (Mex); 1985; 16(3):237-45. PubMed ID: 2870690
    [No Abstract]   [Full Text] [Related]  

  • 10. Hereditary medullary thyroid carcinoma.
    Vasen HF; Vermey A
    Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A familial case of multiple endocrine neoplasia (MEN IIb). Diagnosis of medullary thyroid cancer].
    Rochiccioli P; Tauber MT; Pienkowski C
    J Genet Hum; 1989 Sep; 37(3):207-14. PubMed ID: 2576280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
    Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
    Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple endocrine neoplasia type 2: familial variant of medullary carcinoma of the thyroid gland].
    Neradilová M; Soutorová M; Vlcek P
    Vnitr Lek; 1992 Sep; 38(9):850-9. PubMed ID: 1362306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for the familial form of medullary cancer of the thyroid].
    Allannic H
    Bull Cancer; 1984; 71(2):125-9. PubMed ID: 6733292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma.
    Grauer A; Raue F; Gagel RF
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):613-35. PubMed ID: 1979773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple endocrine neoplasia-type medullary thyroid carcinoma in three generations of a family].
    Takácsi NZ; Poller I; Trón L; Dabasi G; Rákóczy G; Füzy M; Szentirmay Z; Esik O
    Orv Hetil; 1998 Nov; 139(48):2883-8. PubMed ID: 9868902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early detection of medullary thyroid carcinoma in multiple endocrine neoplasia type II].
    Ezabella MC; Hayashida CY; Bisi H; Leite MO; Borelli A; Abelin NM; Cordeiro AC; Camargo RY; Toledo SP
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(3):105-9. PubMed ID: 1983764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medullary carcinoma of the thyroid: a case of multiple endocrine neoplasia type 2A].
    Pati M; Sperti P; Magiar AV; Bonifacio V
    Minerva Endocrinol; 1994 Mar; 19(1):29-32. PubMed ID: 7913514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma.
    Corsello SM; Lovicu RM; Migneco MG; Rufini V; Summaria V
    Rays; 2000; 25(2):257-66. PubMed ID: 11370543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.